Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.
Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro
Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...